The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Enoxaparin Sodium For Injection Market Research Report 2025

Global Enoxaparin Sodium For Injection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1702842

No of Pages : 93

Synopsis
Due to the COVID-19 pandemic, the global Enoxaparin Sodium For Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Enoxaparin Sodium For Injection market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Enoxaparin Sodium For Injection landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
40mg accounting for % of the Enoxaparin Sodium For Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Prevents Intravenous Thrombosis segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Enoxaparin Sodium For Injection include Sanofi, Teva Pharmaceutical, Techdow (Hepalink), Fresenius Kabi, Amphastar Pharmaceuticals, Hangzhou Jiuyuan Gene Engineering, Suzhou Erye Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical and Chengdu Baiyu Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Enoxaparin Sodium For Injection in 2021.
This report focuses on Enoxaparin Sodium For Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Enoxaparin Sodium For Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Enoxaparin Sodium For Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type

  • 40mg
  • 100mg
  • Other

Segment by Application

  • Prevents Intravenous Thrombosis
  • Deep Vein Embolism Treatment
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Sanofi
  • Teva Pharmaceutical
  • Techdow (Hepalink)
  • Fresenius Kabi
  • Amphastar Pharmaceuticals
  • Hangzhou Jiuyuan Gene Engineering
  • Suzhou Erye Pharmaceutical
  • Nanjing King-friend Biochemical Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Beijing SL Pharmaceutical
  • Troikaa Pharmaceuticals
Index

1 Enoxaparin Sodium For Injection Market Overview
1.1 Product Overview and Scope of Enoxaparin Sodium For Injection
1.2 Enoxaparin Sodium For Injection Segment by Type
1.2.1 Global Enoxaparin Sodium For Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 40mg
1.2.3 100mg
1.2.4 Other
1.3 Enoxaparin Sodium For Injection Segment by Application
1.3.1 Global Enoxaparin Sodium For Injection Sales Comparison by Application: (2022-2028)
1.3.2 Prevents Intravenous Thrombosis
1.3.3 Deep Vein Embolism Treatment
1.3.4 Other
1.4 Global Enoxaparin Sodium For Injection Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin Sodium For Injection Revenue 2017-2028
1.4.2 Global Enoxaparin Sodium For Injection Sales 2017-2028
1.4.3 Enoxaparin Sodium For Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Enoxaparin Sodium For Injection Market Competition by Manufacturers
2.1 Global Enoxaparin Sodium For Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Enoxaparin Sodium For Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Enoxaparin Sodium For Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Enoxaparin Sodium For Injection Manufacturing Sites, Area Served, Product Type
2.5 Enoxaparin Sodium For Injection Market Competitive Situation and Trends
2.5.1 Enoxaparin Sodium For Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium For Injection Players Market Share by Revenue
2.5.3 Global Enoxaparin Sodium For Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enoxaparin Sodium For Injection Retrospective Market Scenario by Region
3.1 Global Enoxaparin Sodium For Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Enoxaparin Sodium For Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Enoxaparin Sodium For Injection Market Facts & Figures by Country
3.3.1 North America Enoxaparin Sodium For Injection Sales by Country
3.3.2 North America Enoxaparin Sodium For Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Enoxaparin Sodium For Injection Market Facts & Figures by Country
3.4.1 Europe Enoxaparin Sodium For Injection Sales by Country
3.4.2 Europe Enoxaparin Sodium For Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Enoxaparin Sodium For Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Enoxaparin Sodium For Injection Sales by Region
3.5.2 Asia Pacific Enoxaparin Sodium For Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Enoxaparin Sodium For Injection Market Facts & Figures by Country
3.6.1 Latin America Enoxaparin Sodium For Injection Sales by Country
3.6.2 Latin America Enoxaparin Sodium For Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Enoxaparin Sodium For Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Enoxaparin Sodium For Injection Sales by Country
3.7.2 Middle East and Africa Enoxaparin Sodium For Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Enoxaparin Sodium For Injection Historic Market Analysis by Type
4.1 Global Enoxaparin Sodium For Injection Sales Market Share by Type (2017-2022)
4.2 Global Enoxaparin Sodium For Injection Revenue Market Share by Type (2017-2022)
4.3 Global Enoxaparin Sodium For Injection Price by Type (2017-2022)
5 Global Enoxaparin Sodium For Injection Historic Market Analysis by Application
5.1 Global Enoxaparin Sodium For Injection Sales Market Share by Application (2017-2022)
5.2 Global Enoxaparin Sodium For Injection Revenue Market Share by Application (2017-2022)
5.3 Global Enoxaparin Sodium For Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Enoxaparin Sodium For Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Corporation Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Teva Pharmaceutical Enoxaparin Sodium For Injection Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Techdow (Hepalink)
6.3.1 Techdow (Hepalink) Corporation Information
6.3.2 Techdow (Hepalink) Description and Business Overview
6.3.3 Techdow (Hepalink) Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Techdow (Hepalink) Enoxaparin Sodium For Injection Product Portfolio
6.3.5 Techdow (Hepalink) Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Fresenius Kabi Enoxaparin Sodium For Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Amphastar Pharmaceuticals
6.5.1 Amphastar Pharmaceuticals Corporation Information
6.5.2 Amphastar Pharmaceuticals Description and Business Overview
6.5.3 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Product Portfolio
6.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.6 Hangzhou Jiuyuan Gene Engineering
6.6.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
6.6.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview
6.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Product Portfolio
6.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.7 Suzhou Erye Pharmaceutical
6.6.1 Suzhou Erye Pharmaceutical Corporation Information
6.6.2 Suzhou Erye Pharmaceutical Description and Business Overview
6.6.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Product Portfolio
6.7.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
6.8 Nanjing King-friend Biochemical Pharmaceutical
6.8.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
6.8.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.8.3 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Product Portfolio
6.8.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.9 Chengdu Baiyu Pharmaceutical
6.9.1 Chengdu Baiyu Pharmaceutical Corporation Information
6.9.2 Chengdu Baiyu Pharmaceutical Description and Business Overview
6.9.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Product Portfolio
6.9.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
6.10 Hebei Changshan Biochemical Pharmaceutical

6.10.1 Hebei Changshan Biochemical Pharmaceutical
Corporation Information
6.10.2 Hebei Changshan Biochemical Pharmaceutical
Description and Business Overview
6.10.3 Hebei Changshan Biochemical Pharmaceutical
Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Hebei Changshan Biochemical Pharmaceutical
Enoxaparin Sodium For Injection Product Portfolio
6.10.5 Hebei Changshan Biochemical Pharmaceutical
Recent Developments/Updates
6.11 Beijing SL Pharmaceutical
6.11.1 Beijing SL Pharmaceutical Corporation Information
6.11.2 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Description and Business Overview
6.11.3 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Product Portfolio
6.11.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.12 Troikaa Pharmaceuticals
6.12.1 Troikaa Pharmaceuticals Corporation Information
6.12.2 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Description and Business Overview
6.12.3 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Product Portfolio
6.12.5 Troikaa Pharmaceuticals Recent Developments/Updates
7 Enoxaparin Sodium For Injection Manufacturing Cost Analysis
7.1 Enoxaparin Sodium For Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Enoxaparin Sodium For Injection
7.4 Enoxaparin Sodium For Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Enoxaparin Sodium For Injection Distributors List
8.3 Enoxaparin Sodium For Injection Customers
9 Enoxaparin Sodium For Injection Market Dynamics
9.1 Enoxaparin Sodium For Injection Industry Trends
9.2 Enoxaparin Sodium For Injection Market Drivers
9.3 Enoxaparin Sodium For Injection Market Challenges
9.4 Enoxaparin Sodium For Injection Market Restraints
10 Global Market Forecast
10.1 Enoxaparin Sodium For Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Enoxaparin Sodium For Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Enoxaparin Sodium For Injection by Type (2023-2028)
10.2 Enoxaparin Sodium For Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Enoxaparin Sodium For Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Enoxaparin Sodium For Injection by Application (2023-2028)
10.3 Enoxaparin Sodium For Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Enoxaparin Sodium For Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Enoxaparin Sodium For Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Enoxaparin Sodium For Injection Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Enoxaparin Sodium For Injection Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Enoxaparin Sodium For Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Enoxaparin Sodium For Injection Market Competitive Situation by Manufacturers in 2021
Table 5. Global Enoxaparin Sodium For Injection Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Enoxaparin Sodium For Injection Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Enoxaparin Sodium For Injection Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Enoxaparin Sodium For Injection Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Enoxaparin Sodium For Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Enoxaparin Sodium For Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Enoxaparin Sodium For Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Enoxaparin Sodium For Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enoxaparin Sodium For Injection as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Enoxaparin Sodium For Injection Sales by Region (2017-2022) & (Units)
Table 16. Global Enoxaparin Sodium For Injection Sales Market Share by Region (2017-2022)
Table 17. Global Enoxaparin Sodium For Injection Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Enoxaparin Sodium For Injection Revenue Market Share by Region (2017-2022)
Table 19. North America Enoxaparin Sodium For Injection Sales by Country (2017-2022) & (Units)
Table 20. North America Enoxaparin Sodium For Injection Sales Market Share by Country (2017-2022)
Table 21. North America Enoxaparin Sodium For Injection Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Enoxaparin Sodium For Injection Revenue Market Share by Country (2017-2022)
Table 23. Europe Enoxaparin Sodium For Injection Sales by Country (2017-2022) & (Units)
Table 24. Europe Enoxaparin Sodium For Injection Sales Market Share by Country (2017-2022)
Table 25. Europe Enoxaparin Sodium For Injection Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Enoxaparin Sodium For Injection Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Enoxaparin Sodium For Injection Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Enoxaparin Sodium For Injection Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Enoxaparin Sodium For Injection Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Enoxaparin Sodium For Injection Revenue Market Share by Region (2017-2022)
Table 31. Latin America Enoxaparin Sodium For Injection Sales by Country (2017-2022) & (Units)
Table 32. Latin America Enoxaparin Sodium For Injection Sales Market Share by Country (2017-2022)
Table 33. Latin America Enoxaparin Sodium For Injection Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Enoxaparin Sodium For Injection Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Enoxaparin Sodium For Injection Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Enoxaparin Sodium For Injection Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Enoxaparin Sodium For Injection Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Enoxaparin Sodium For Injection Revenue Market Share by Country (2017-2022)
Table 39. Global Enoxaparin Sodium For Injection Sales by Type (2017-2022) & (Units)
Table 40. Global Enoxaparin Sodium For Injection Sales Market Share by Type (2017-2022)
Table 41. Global Enoxaparin Sodium For Injection Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Enoxaparin Sodium For Injection Revenue Share by Type (2017-2022)
Table 43. Global Enoxaparin Sodium For Injection Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Enoxaparin Sodium For Injection Sales (Units) by Application (2017-2022)
Table 45. Global Enoxaparin Sodium For Injection Sales Market Share by Application (2017-2022)
Table 46. Global Enoxaparin Sodium For Injection Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Enoxaparin Sodium For Injection Revenue Share by Application (2017-2022)
Table 48. Global Enoxaparin Sodium For Injection Price by Application (2017-2022) & (US$/Unit)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Sanofi Enoxaparin Sodium For Injection Product
Table 53. Sanofi Recent Developments/Updates
Table 54. Teva Pharmaceutical Corporation Information
Table 55. Teva Pharmaceutical Description and Business Overview
Table 56. Teva Pharmaceutical Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Teva Pharmaceutical Enoxaparin Sodium For Injection Product
Table 58. Teva Pharmaceutical Recent Developments/Updates
Table 59. Techdow (Hepalink) Corporation Information
Table 60. Techdow (Hepalink) Description and Business Overview
Table 61. Techdow (Hepalink) Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Techdow (Hepalink) Enoxaparin Sodium For Injection Product
Table 63. Techdow (Hepalink) Recent Developments/Updates
Table 64. Fresenius Kabi Corporation Information
Table 65. Fresenius Kabi Description and Business Overview
Table 66. Fresenius Kabi Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Fresenius Kabi Enoxaparin Sodium For Injection Product
Table 68. Fresenius Kabi Recent Developments/Updates
Table 69. Amphastar Pharmaceuticals Corporation Information
Table 70. Amphastar Pharmaceuticals Description and Business Overview
Table 71. Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Product
Table 73. Amphastar Pharmaceuticals Recent Developments/Updates
Table 74. Hangzhou Jiuyuan Gene Engineering Corporation Information
Table 75. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
Table 76. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Product
Table 78. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
Table 79. Suzhou Erye Pharmaceutical Corporation Information
Table 80. Suzhou Erye Pharmaceutical Description and Business Overview
Table 81. Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Product
Table 83. Suzhou Erye Pharmaceutical Recent Developments/Updates
Table 84. Nanjing King-friend Biochemical Pharmaceutical Corporation Information
Table 85. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 86. Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Product
Table 88. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 89. Chengdu Baiyu Pharmaceutical Corporation Information
Table 90. Chengdu Baiyu Pharmaceutical Description and Business Overview
Table 91. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Product
Table 93. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
Table 94. Hebei Changshan Biochemical Pharmaceutical
Corporation Information
Table 95. Hebei Changshan Biochemical Pharmaceutical
Description and Business Overview
Table 96. Hebei Changshan Biochemical Pharmaceutical
Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Hebei Changshan Biochemical Pharmaceutical
Enoxaparin Sodium For Injection Product
Table 98. Hebei Changshan Biochemical Pharmaceutical
Recent Developments/Updates
Table 99. Beijing SL Pharmaceutical Corporation Information
Table 100. Beijing SL Pharmaceutical Description and Business Overview
Table 101. Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Product
Table 103. Beijing SL Pharmaceutical Recent Developments/Updates
Table 104. Troikaa Pharmaceuticals Corporation Information
Table 105. Troikaa Pharmaceuticals Description and Business Overview
Table 106. Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Product
Table 108. Troikaa Pharmaceuticals Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Enoxaparin Sodium For Injection Distributors List
Table 112. Enoxaparin Sodium For Injection Customers List
Table 113. Enoxaparin Sodium For Injection Market Trends
Table 114. Enoxaparin Sodium For Injection Market Drivers
Table 115. Enoxaparin Sodium For Injection Market Challenges
Table 116. Enoxaparin Sodium For Injection Market Restraints
Table 117. Global Enoxaparin Sodium For Injection Sales Forecast by Type (2023-2028) & (Units)
Table 118. Global Enoxaparin Sodium For Injection Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Enoxaparin Sodium For Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Enoxaparin Sodium For Injection Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Enoxaparin Sodium For Injection Sales Forecast by Application (2023-2028) & (Units)
Table 122. Global Enoxaparin Sodium For Injection Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Enoxaparin Sodium For Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Enoxaparin Sodium For Injection Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Enoxaparin Sodium For Injection Sales Forecast by Region (2023-2028) & (Units)
Table 126. Global Enoxaparin Sodium For Injection Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Enoxaparin Sodium For Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Enoxaparin Sodium For Injection Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enoxaparin Sodium For Injection
Figure 2. Global Enoxaparin Sodium For Injection Market Share by Type in 2021 & 2028
Figure 3. 40mg Product Picture
Figure 4. 100mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Enoxaparin Sodium For Injection Market Share by Application in 2021 & 2028
Figure 7. Prevents Intravenous Thrombosis
Figure 8. Deep Vein Embolism Treatment
Figure 9. Other
Figure 10. Global Enoxaparin Sodium For Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Enoxaparin Sodium For Injection Market Size (2017-2028) & (US$ Million)
Figure 12. Global Enoxaparin Sodium For Injection Sales (2017-2028) & (Units)
Figure 13. Enoxaparin Sodium For Injection Sales Share by Manufacturers in 2021
Figure 14. Global Enoxaparin Sodium For Injection Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Enoxaparin Sodium For Injection Players: Market Share by Revenue in 2021
Figure 16. Enoxaparin Sodium For Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Enoxaparin Sodium For Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Enoxaparin Sodium For Injection Sales Market Share by Region in 2021
Figure 19. Global Enoxaparin Sodium For Injection Revenue Market Share by Region (2017-2022)
Figure 20. Global Enoxaparin Sodium For Injection Revenue Market Share by Region in 2021
Figure 21. United States Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Enoxaparin Sodium For Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Enoxaparin Sodium For Injection by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Enoxaparin Sodium For Injection
Figure 45. Manufacturing Process Analysis of Enoxaparin Sodium For Injection
Figure 46. Enoxaparin Sodium For Injection Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’